Please login to the form below

Not currently logged in
Email:
Password:

Astellas taps Lilly for comms chief

Jeffrey Winton appointed first chief communications officer
Jeffrey Winton

Astellas US has announced that Lilly's Jeffrey Winton will be the company's first senior vice president, chief communications officer.

Winton was vice president and head, global communications at Lilly, belonging to the global corporate affairs leadership team.

He will be responsible for corporate branding and reputation management in the US, reporting to Masao Yoshida, chief executive officer of Tokyo-based parent company Astellas Pharma. He has more than 30 years of communications experience in the pharmaceutical industry.

Prior to joining Lilly, Winton held senior communications roles at major global pharmaceutical companies such as Schering-Plough and Pharmacia. He has a degree in life sciences from Cornell University in Ithaca, New York.

"I am pleased to add Jeff to our senior management team at Astellas," said Yoshida. "He brings with him the broad industry expertise and experience we are looking for to help propel the Astellas brand in the Americas."


5th November 2013

From: PME

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics